Characteristics of the env genes of HIV type 1 quasispecies in long-term nonprogressors with broadly neutralizing antibodies

被引:22
作者
Braibant, Martine [1 ]
Agut, Henri [2 ]
Rouzioux, Christine [3 ]
Costagliola, Dominique [4 ]
Autran, Brigitte [5 ]
Barin, Francis [1 ]
机构
[1] Univ Tours, Tours, France
[2] Hop La Pitie Salpetriere, Virol Lab, Paris, France
[3] Hop Necker Enfants Malad, Virol Lab, Paris, France
[4] Univ Paris 06, Paris, France
[5] Hop Pietie Salpetriere, Lab Immunol Celulaire & Tissulaire, Paris, France
关键词
neutralizing antibody; long-term nonprogressors; gp120 envelope glycoprotein;
D O I
10.1097/QAI.0b013e318162cac2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Primary isolates of different subtypes of HIV-1 can be neutralized in vitro by the broadly neutralizing antibodies (NAbs) found in the sera of a small number of HIV-1-infected patients. This broad response is most frequent in long-term nonprogressors (LTNPs). We investigated whether the presence of NAbs in the sera of some LTNPs was associated with particular properties of the envelope glycoproteins of the variants found in these patients. Toward that aim, 147 env gene fragments (encoding almost the entire gp 120) amplified from the proviral DNA of 5 LTNPs who developed broadly NAbs (NAb+) and of 4 LTNPs who did not develop such broadly NAbs (NAb-) were cloned, sequenced, and compared. We found that the development of broadly NAbs was associated with high viral loads, greater diversity in the gp120 of the viruses infecting these patients, and longer V I sequences and additional N-gly sites in VI. In addition, a higher proportion of defective clones was found among the env genes of NAb- patients (25% to 93 %)-particularly those with lower viral loads and low levels of env diversity-than among those of NAb+ patients (7% to 19%).
引用
收藏
页码:274 / 284
页数:11
相关论文
共 66 条
  • [1] HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus
    Altfeld, M
    Allen, TM
    Yu, XG
    Johnston, MN
    Agrawal, D
    Korber, BT
    Montefiori, DC
    O'Connor, DH
    Davis, BT
    Lee, PK
    Maier, EL
    Harlow, J
    Goulder, PJR
    Brander, C
    Rosenberg, ES
    Walker, BD
    [J]. NATURE, 2002, 420 (6914) : 434 - 439
  • [2] [Anonymous], 2001, COMPUTATIONAL EVOLUT
  • [3] Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
    Baba, TW
    Liska, V
    Hofmann-Lehmann, R
    Vlasak, J
    Xu, WD
    Ayehunie, S
    Cavacini, LA
    Posner, MR
    Katinger, H
    Stiegler, G
    Bernacky, BJ
    Rizvi, TA
    Schmidt, R
    Hill, LR
    Keeling, ME
    Lu, YC
    Wright, JE
    Chou, TC
    Ruprecht, RM
    [J]. NATURE MEDICINE, 2000, 6 (02) : 200 - 206
  • [4] Structural analysis of the epitope of the Anti-HIV antibody 2F5 sheds light into its mechanism of neutralization and HIV fusion
    Barbato, G
    Bianchi, E
    Ingallinella, P
    Hurni, WH
    Miller, MD
    Cilibertol, G
    Cortese, R
    Bazzo, R
    Shiver, JW
    Pessi, A
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2003, 330 (05) : 1101 - 1115
  • [5] Revisiting the role of neutralizing antibodies in mother-to-child transmission of HIV-1
    Barin, F
    Jourdain, G
    Brunet, S
    Ngo-Giang-Huong, N
    Weerawatgoompa, S
    Karnchanamayul, W
    Ariyadej, S
    Hansudewechakul, R
    Achalapong, J
    Yuthavisuthi, P
    Ngampiyaskul, C
    Bhakeecheep, S
    Hemwutthiphan, C
    Lallemant, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (11) : 1504 - 1511
  • [6] Interclade neutralization and enhancement of human immunodeficiency virus type 1 identified by an assay using HeLa cells expressing both CD4 receptor and CXCR4/CCR5 coreceptors
    Barin, F
    Brunet, S
    Brand, D
    Moog, C
    Peyre, R
    Damond, F
    Charneau, P
    Barre-Sinoussi, F
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (02) : 322 - 327
  • [7] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
    BARRESINOUSSI, F
    CHERMANN, JC
    REY, F
    NUGEYRE, MT
    CHAMARET, S
    GRUEST, J
    DAUGUET, C
    AXLERBLIN, C
    VEZINETBRUN, F
    ROUZIOUX, C
    ROZENBAUM, W
    MONTAGNIER, L
    [J]. SCIENCE, 1983, 220 (4599) : 868 - 871
  • [8] A subset of human immunodeficiency virus type 1 long-term non-progressors is characterized by the unique presence of ancestral sequences in the viral population
    Bello, G
    Casado, C
    Sandonis, V
    Alonso-Nieto, M
    Vicario, JL
    García, S
    Hernando, V
    Rodríguez, C
    del Romero, J
    López-Galíndez, C
    [J]. JOURNAL OF GENERAL VIROLOGY, 2005, 86 : 355 - 364
  • [9] Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
    Binley, JA
    Wrin, T
    Korber, B
    Zwick, MB
    Wang, M
    Chappey, C
    Stiegler, G
    Kunert, R
    Zolla-Pazner, S
    Katinger, H
    Petropoulos, CJ
    Burton, DR
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (23) : 13232 - 13252
  • [10] Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity
    Braibant, Martine
    Brunet, Sylvie
    Costagliola, Dominique
    Rouzioux, Christine
    Agut, Henri
    Katinger, Hermann
    Autran, Brigitte
    Barin, Francis
    [J]. AIDS, 2006, 20 (15) : 1923 - 1930